Data comparing the plasma levels of procollagen C-proteinase enhancer 1 (PCPE-1) in healthy individuals and liver fibrosis patients
Eyal Hassoun,
Mary Safrin,
Eitan Wineman,
Peretz Weiss,
Efrat Kessler
Affiliations
Eyal Hassoun
Maurice and Gabriela Goldschleger Eye Research Institute, Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel
Mary Safrin
Maurice and Gabriela Goldschleger Eye Research Institute, Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel
Eitan Wineman
Maurice and Gabriela Goldschleger Eye Research Institute, Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel
Peretz Weiss
Liver Disease Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel
Efrat Kessler
Maurice and Gabriela Goldschleger Eye Research Institute, Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel
This article provides a protocol for determination of human procollagen C-proteinase enhancer 1 (PCPE-1) concentrations by ELISA. The inter-assay and intra-assay coefficients of variability are given and so are the average plasma concentrations of PCPE-1 in healthy (control) individuals and liver fibrosis patients.
